🎉BIO is excited to welcome our new members from the past month! Together, we're advancing innovation and the future of biotechnology.
Biotechnology Innovation Organization
Biotechnology Research
Washington, DC 91,859 followers
BIO, Where breakthroughs begin
About us
BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. We also represent state and regional biotech associations, service providers to the industry and academic centers.
- Website
-
http://www.bio.org
External link for Biotechnology Innovation Organization
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Washington, DC
- Type
- Nonprofit
- Founded
- 1993
- Specialties
- biotech, association, life sciences, biofuels, gmo, cures, energy, agriculture, and pharmaceuticals
Locations
-
Primary
1201 New York Ave N.W.
Suite 1300
Washington, DC 20005, US
Employees at Biotechnology Innovation Organization
Updates
-
Yesterday, the heads of the three largest pharmacy benefit managers (#PBMs) faced the House Oversight and Accountability Committee, whose new report found “PBMs inflate prescription drug costs and interfere with patient care for their own financial benefit.” Read more: https://lnkd.in/dNz-ghA5
-
Biotechnology Innovation Organization reposted this
Today we’re opening our flagship U.S. facility in Hopewell, N.J. to help advance current and future innovative medicines to meet the needs of more patients with #cancer. This 42-acre site houses state-of-the-art biologics manufacturing capabilities and a clinical R&D center that will continue expanding and scaling our unique capabilities around the world. https://lnkd.in/evxVxsY6
-
Check out a discussion with BIO's President & CEO John F. Crowley and a16z Bio Health's Jorge Conde about the importance of balanced policies for biotech innovation.
How can we avoid disrupting the golden age of medicine with ineffective policies? John F. Crowley, CEO of Biotechnology Innovation Organization, joins a16z general partner, Jorge Conde, to discuss how poorly designed policies could hinder both innovation and access to critical treatments. When considering the breakthroughs in the biotech industry, it’s essential to balance regulatory measures to foster growth without unintended consequences. The duo emphasize that the focus must be on facilitating patient-centered innovation, removing barriers, and ensuring no patient is left without necessary medicines. Listen on Raising Health: https://lnkd.in/g26nuCYX
-
Registration is now open for #BIF24! Join us in San Francisco for two days of insightful panel discussions, company presentations, and BIO One-on-One Partnering™ meetings. Register now: https://lnkd.in/dFy3uU4W
-
Today marks the 20th anniversary of Project BioShield! We interviewed former Sen. Richard Burr on Project BioShield's legacy and the urgent need to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA). Read more: https://lnkd.in/erp-vCXY
Exclusive: Sen. Burr on the legacy of Project BioShield and the urgency of PAHPA reauthorization
https://bio.news
-
The transportation sector emits more greenhouse gas emissions than other sectors. Biotech has the potential to decarbonize all modes of transportation using sustainable sources like plants and waste. #ABCsofClimateTech Learn how it impacts aviation: https://lnkd.in/evi-Ex9i
-
BIO Commends the FDA's plan to establish a Rare Disease Innovation Hub to advance rare disease collaboration and treatments. Read more: https://lnkd.in/e9rQpJE8
BIO Commends FDA Plan to Establish a Rare Disease Innovation Hub to advance rare disease collaboration, treatments | BIO
bio.org
-
BIO Board member Frank Watanabe and BioUtah CEO Kelvyn Cullimore shared their expertise at the House Ways and Means Committee hearing, advocating for policies that foster #biotech breakthroughs. Read more: https://lnkd.in/eixdyTxq
-
BIO members Ginkgo Bioworks, Inc. and Bayer are in a multi-year strategic partnership to accelerate the research and development of synthetic biological products for agriculture. #ABCsofClimateTech Learn more: https://lnkd.in/eSv4WWud